Evidence map›Paper›PMID 38327133›Full record

Trial reportESC heart failure2024

S

Junyi Sun, Zhengshuo Xie, Min Ye, He Xu, Yugang Dong, Chen Liu, Wengen Zhu

Abstract readRandomized Controlled TrialMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Trial report in ESC heart failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. SESC heart failure · 2024
    Trial
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Junyi SunDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.ORCID https://orcid.org/0000-0002-0933-3536
Zhengshuo XieDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Min YeDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
He XuCenter of Translational Medicine, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Yugang DongDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Chen LiuDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.
Wengen ZhuDepartment of Cardiology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510080, China.ORCID https://orcid.org/0000-0002-1280-0158

Funding

National Natural Science Foundation of China 81970340National Natural Science Foundation of China 82000260National Natural Science Foundation of China 82100273National Natural Science Foundation of China 82370383
6 · The paper itself

Abstract

aimsThis study investigated the S METHODS AND

resultsAnalysing 890 GUIDE-IT HFrEF trial participants, we stratified them by baseline S

conclusionsThe S

Indexed as

Heart FailureStroke VolumeAgedCause of DeathFemaleFollow-Up StudiesHumansMaleMiddle AgedMorbidityNatriuretic Peptide, BrainPeptide FragmentsPrognosisRisk AssessmentRisk FactorsSurvival RateNatriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Heart failurePredictive valueRisk scoreRisk stratificationS2I2N0–3

Identifiers

PMID38327133
PMCPMC11098633

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.